Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

global access

Gilead Sciences

Gilead gets US approval for Sovaldi follow-up Harvoni

Company claims it could cure 90 percent of patients within eight weeks

National Institute for Health and Care Excellence NICE logo

NICE publishes its first medicines optimisation guidance

Draft guidelines encourage patient-centred care and improved NHS communications

- PMLiVE

EMA safety panel rules no change needed for Ariad’s Iclusig

Positive news comes after blood clot concerns

- PMLiVE

Sanofi looks to AstraZeneca for new UK & Ireland head

Tarja Stenvall replaces Steve Oldfield

- PMLiVE

Eisai wins US approval for chemotherapy side effects drug

FDA backs Akynzeo to treat nausea and vomiting

Pharma deals during September 2014

Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month

Deal Watch table for September 2014

Table listing all the major pharma mergers, acquisitions and collaborations in the past month

- PMLiVE

Go with the flow: lab-on-a-chip devices

Microfluidic, or lab-on-a-chip, devices have been used by pharma scientists for years but are now threatening to break into mainstream use

- PMLiVE

Endo to acquire Auxilium for $2.6bn

Puts end to takeover deal for QLT

- PMLiVE

Amgen leukaemia drug gets FDA priority review

Adds to breakthrough status for blinatumomab

Novartis building

Novartis’ secukinumab has ‘consistent’ activity in psoriasis

Reinforces data that suggests drug is more effective than Amgen’s Enbrel

- PMLiVE

EMG appoints Merck and Boehringer directors as new officers

David Garmon-Jones is new chair and Zinta Krumins is vice chair

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links